medigraphic.com
SPANISH

Enfermedades Infecciosas y Microbiología

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 2

<< Back Next >>

Enf Infec Microbiol 2024; 44 (2)

Tetanus in children: new perspectives and updated approaches

Reyes GU, Montaño AA, García CC, Hernández GMA, Reyes HKL, Ayuzo VC
Full text How to cite this article

Language: Spanish
References: 17
Page: 62-69
PDF size: 463.57 Kb.


Key words:

Clostridium tetani, tetanus, immunization, children.

ABSTRACT

Tetanus is a severe and potentially fatal disease caused by the exotoxin tetanospasmin, produced by certain strains of Clostridium tetani. C. tetani is a gram-positive, non-encapsulated, strictly anaerobic bacillus. The natural habitat of Clostridium tetani is the soil. The spores have a wide distribution in the soil, the digestive tract, the feces of horses, sheep, cattle, dogs, cats, rats, guinea pigs, chickens, and humans, predominantly in warm and humid agricultural areas. Soil treated with manure can contain significant spores quantities. Clinical manifestation include facial muscles contractions, leading to trismus, where the lower jaw locks, and giving rise to a facial expression recognized as a “sardonic grin”. These initial signs are followed by contractions in the back muscles, resulting in an arched posture referred to as opisthotonos. Finally, sudden and generalized convulsions, known as tetanic spasms, are triggered. Any individual is at risk of acquiring tetanus, but is more frequent ad severe in newborns and elderly adults who have incomplete or have not been received tetanus toxoid vaccination. This serves as a fundamental review that every primary care physician should know and implement, focusing on comprehensive and specific vaccination strategies for all age groups, but particularly in children.


REFERENCES

  1. Bennett, J.E., Dolin, R. y Blaser, M.J. (eds.), Mandell,Douglas, and Bennett’s principles and practice of infectiousdiseases, 9ª ed., Filadelfia, Elsevier, 2020.

  2. States, M., Strategic who, Group a, Grade t y Sage, T.,“Tetanus vaccines: who position paper, February 2017”,Releve Epidemiol Hebd, 2017, 92 (6): 53-76.

  3. Secretaría de Salud, Dirección General de Epidemiología,“Manual de Procedimientos Estandarizados para laVigilancia Epidemiológica de las Enfermedades Preveniblespor Vacunación”, 2018. Disponible en: https://epidemiologia.salud.gob.mx/gobmx/salud/documentos/manuales/35_Manual_VE_EPV.pdf.

  4. Secretaría de Salud, Sistema Nacional de Epidemiología(Sinave), “Boletín epidemiológico. Sistema nacional devigilancia epidemiológica. Sistema único de información”,2023. Disponible en: https://www.gob.mx/salud/acciones-y-programas/historico-boletin-epidemiologico.

  5. Tiwari, T., Moro, P. y Acosta, A., “Tetanus”, cdc EpidemiolPrev Vaccine-Prev Dis, 2021, 315-328.

  6. Hall, E., Wodi, P., Hamborsky, J., Morelli, V., Schillie, S.,Tiwari, T. et al., “Tetanus”. En Epidemiology and preventionof vaccine: preventable diseases, 14ª ed., Washington,Public Health Foundation, 2021, pp. 315-327.Disponible en: https://www.merle-arbeitsmedizin.de/wp-content/uploads/2022/02/CDC-Pink-Book-Version-14th-Edition.pdf.

  7. Yen, L.M. y Thwaites, C.L., “Tetanus”, The Lancet, 2019,393 (10181): 1657-1668.

  8. Cohen, J.E., Wang, R., Shen, R.F., Wu, W.W. y Keller,J.E., “Comparative pathogenomics of Clostridium tetani”,plos One, 2017, 12 (8): 1-24.

  9. Rhinesmith, E. y Fu, L., “Tetanus disease, treatment,management”, Pediatr Rev, 2018, 39 (8): 430-432.

  10. Centers of Disease Control and Prevention, The epidemiologyand prevention of vaccine-preventablediseases, 2021. Disponible en: https://www.cdc.gov/vaccines/pubs/pinkbook/tetanus.html.

  11. Kilegman, R.M., Geme, J.S., Blum, N., Shah, S.S., Tasker,R. y Nelson, C., Tratado de Pediatría, vol. 1, 21ª ed.,Elsevier, 2020.

  12. Kimberlin, D.W., Brady, M.T., Jackson, M.A., Long, S.S.,Committee on Infectious Diseases, Red Book 2018-2021, 31ª ed., American Academy of Pediatrics, 2021.

  13. Pereira-Victorio, C.J., Saldívar-Tapia, T.L. y Valladares-Garrido,M.J., “Coberturas de vacunación en tiempos decovid-19: un análisis desde la epidemiología social enla región del Cusco”, Rev Cuerpo Méd hnaaa, 2020, 13(2):167-174.

  14. OMS, “Tétanos”, 2023. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/tetanus.

  15. Plourde, L., Bouchier, C. et al., “The population structureof Clostridium tetani deduced from its pan-genome”,Sci Rep, 2019, 9: 11220. Disponible en: https://doi.org/10.1038/s41598-019-47551-4.

  16. Doxey, A.C., Mansfeld, M.J. y Montecucco, C., “Discoveryof novel bacterial toxins by genomics and computationalbiology”, Toxicon, 2018, 147: 2-12.

  17. Garrigues, L., Do, T.D., Bideaux, C., Guillouet, S.E. yMeynial-Salles, I., “Insights into Clostridium tetani: fromgenome to bioreactors”, Biotechnol Adv, 2022, 54:107781. doi: 10.1016/j.biotechadv.2021.107781.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Enf Infec Microbiol. 2024;44